Chandra Bhagat Pharma (BOM:542934) Inventories, Raw Materials & Components: ₹0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:542934 Chandra Bhagat Pharma Ltd BOM:542934
65 GF Score
Price ₹34.79
GF Value ₹70.19
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Chandra Bhagat Pharma Inventories, Raw Materials & Components?

Chandra Bhagat Pharma BOM:542934 +4.98% 65 Inventories, Raw Materials & Components is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:542934 with a GF Score™ of 65/100 and a GF Value™ of ₹70.19 (Possible Value Trap). The stock has 4 warning signs investors should review.

Chandra Bhagat Pharma's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ₹0 Mil.

Chandra Bhagat Pharma's quarterly raw materials declined from Mar. 2025 (₹7 Mil) to Sep. 2025 (₹0 Mil) but then stayed the same from Sep. 2025 (₹0 Mil) to Mar. 2026 (₹0 Mil).

Chandra Bhagat Pharma's annual raw materials declined from Mar. 2024 (₹87 Mil) to Mar. 2025 (₹7 Mil) and declined from Mar. 2025 (₹7 Mil) to Mar. 2026 (₹0 Mil).

Chandra Bhagat Pharma Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Chandra Bhagat Pharma's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chandra Bhagat Pharma Inventories, Raw Materials & Components Chart

Chandra Bhagat Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 341.57 290.77 86.77 6.92 0.00

Chandra Bhagat Pharma Semi-Annual Data
Mar17 Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 86.77 0.00 6.92 0.00 0.00
BOM:542934
65GF Score
Chandra Bhagat Pharma Ltd BOM:542934
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chandra Bhagat Pharma Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ₹0 Mil mean?
Chandra Bhagat Pharma (BOM:542934) has a Inventories, Raw Materials & Components of ₹0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Chandra Bhagat Pharma and its competitors.
Is Chandra Bhagat Pharma's Inventories, Raw Materials & Components too high?
Chandra Bhagat Pharma's current Inventories, Raw Materials & Components is ₹0 Mil. Overall, Chandra Bhagat Pharma has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Chandra Bhagat Pharma's Inventories, Raw Materials & Components compare to MCK and CAH?
Chandra Bhagat Pharma's Inventories, Raw Materials & Components of ₹0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Distribution company?
A good Inventories, Raw Materials & Components depends on the Medical Distribution industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Chandra Bhagat Pharma and its competitors. Chandra Bhagat Pharma's current Inventories, Raw Materials & Components is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandra Bhagat Pharma stock overvalued right now?
Based on GuruFocus' analysis, Chandra Bhagat Pharma (BOM:542934) is currently considered Possible Value Trap. The stock's GF Value™ is ₹70.19, compared to a current price of ₹34.79 — trading 50.4% below its estimated fair value. The current Inventories, Raw Materials & Components is ₹0 Mil. Chandra Bhagat Pharma's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Chandra Bhagat Pharma (BOM:542934), the current Inventories, Raw Materials & Components is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chandra Bhagat Pharma (BOM:542934) Overvalued in 2026?

Based on GuruFocus' analysis, Chandra Bhagat Pharma stock appears to be undervalued. The current stock price of ₹34.79 is trading 50.4% below its estimated GF Value™ of ₹70.19. GuruFocus considers Chandra Bhagat Pharma to be Possible Value Trap.

Key valuation signals for BOM:542934:

  • Inventories, Raw Materials & Components: ₹0 Mil
  • GF Value™: ₹70.19 vs. price of ₹34.79 (50.4% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the BOM:542934 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chandra Bhagat Pharma Business Description

Address Doctor Ambedkar Road, 323-F, Flat 1,2, Bhagat Bhuvan, Matunga East, Mumbai, MH, IND, 400019
Chandra Bhagat Pharma Ltd is a pharmaceutical company marketing pharmaceutical, critical care, and health care products across the globe. The company deals in many categories of pharmaceutical products like anticancer, cardiovascular, anti-infective, etc. It offers various forms of pharmaceutical products, like oral solids. tablets, capsules, liquid orals, syrup suspension, injections, liquid, powder, etc. Additionally, the company is also engaged in promoting and marketing of Active Pharmaceutical Ingredients (API's) in India.
65GF Score

Get the complete analysis for BOM:542934

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹34.79
Price
₹70.19
GF Value